351 related articles for article (PubMed ID: 22142592)
1. Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice.
Isacchi B; Bergonzi MC; Grazioso M; Righeschi C; Pietretti A; Severini C; Bilia AR
Eur J Pharm Biopharm; 2012 Apr; 80(3):528-34. PubMed ID: 22142592
[TBL] [Abstract][Full Text] [Related]
2. Stearylamine Liposomal Delivery of Monensin in Combination with Free Artemisinin Eliminates Blood Stages of Plasmodium falciparum in Culture and P. berghei Infection in Murine Malaria.
Rajendran V; Rohra S; Raza M; Hasan GM; Dutt S; Ghosh PC
Antimicrob Agents Chemother; 2015 Dec; 60(3):1304-18. PubMed ID: 26666937
[TBL] [Abstract][Full Text] [Related]
3. Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice.
Isacchi B; Arrigucci S; la Marca G; Bergonzi MC; Vannucchi MG; Novelli A; Bilia AR
J Liposome Res; 2011 Sep; 21(3):237-44. PubMed ID: 21158702
[TBL] [Abstract][Full Text] [Related]
4. Improved efficacy of doxycycline in liposomes against Plasmodium falciparum in culture and Plasmodium berghei infection in mice.
Rajendran V; Singh C; Ghosh PC
Can J Physiol Pharmacol; 2018 Nov; 96(11):1145-1152. PubMed ID: 30075085
[TBL] [Abstract][Full Text] [Related]
5. Liposomes of dimeric artesunate phospholipid: A combination of dimerization and self-assembly to combat malaria.
Ismail M; Ling L; Du Y; Yao C; Li X
Biomaterials; 2018 May; 163():76-87. PubMed ID: 29454237
[TBL] [Abstract][Full Text] [Related]
6. Curcuminoids-loaded liposomes in combination with arteether protects against Plasmodium berghei infection in mice.
Aditya NP; Chimote G; Gunalan K; Banerjee R; Patankar S; Madhusudhan B
Exp Parasitol; 2012 Jul; 131(3):292-9. PubMed ID: 22561991
[TBL] [Abstract][Full Text] [Related]
7. An oral malaria therapy: curcumin-loaded lipid-based drug delivery systems combined with β-arteether.
Memvanga PB; Coco R; Préat V
J Control Release; 2013 Dec; 172(3):904-13. PubMed ID: 24021359
[TBL] [Abstract][Full Text] [Related]
8. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
[TBL] [Abstract][Full Text] [Related]
9. Sustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance.
Nnamani PO; Ugwu AA; Ibezim EC; Kenechukwu FC; Akpa PA; Ogbonna JN; Obitte NC; Odo AN; Windbergs M; Lehr CM; Attama AA
Int J Nanomedicine; 2016; 11():6365-6378. PubMed ID: 27932882
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-artemisinin combination therapy for malaria.
Nandakumar DN; Nagaraj VA; Vathsala PG; Rangarajan P; Padmanaban G
Antimicrob Agents Chemother; 2006 May; 50(5):1859-60. PubMed ID: 16641461
[TBL] [Abstract][Full Text] [Related]
11. Antimalarial Activity of Orally Administered Curcumin Incorporated in Eudragit
Martí Coma-Cros E; Biosca A; Lantero E; Manca ML; Caddeo C; Gutiérrez L; Ramírez M; Borgheti-Cardoso LN; Manconi M; Fernàndez-Busquets X
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734652
[TBL] [Abstract][Full Text] [Related]
12. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
[TBL] [Abstract][Full Text] [Related]
13. Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles.
Omwoyo WN; Melariri P; Gathirwa JW; Oloo F; Mahanga GM; Kalombo L; Ogutu B; Swai H
Nanomedicine; 2016 Apr; 12(3):801-809. PubMed ID: 26724538
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin.
Bayih AG; Folefoc A; Mohon AN; Eagon S; Anderson M; Pillai DR
Malar J; 2016 Dec; 15(1):579. PubMed ID: 27903279
[TBL] [Abstract][Full Text] [Related]
15. Antimalarial chemotherapy: orally curative artemisinin-derived trioxane dimer esters.
Conyers RC; Mazzone JR; Tripathi AK; Sullivan DJ; Posner GH
Bioorg Med Chem Lett; 2015 Jan; 25(2):245-8. PubMed ID: 25481079
[TBL] [Abstract][Full Text] [Related]
16. Nanotized curcumin-benzothiophene conjugate: A potential combination for treatment of cerebral malaria.
Ghosh A; Banerjee T
IUBMB Life; 2020 Dec; 72(12):2637-2650. PubMed ID: 33037778
[TBL] [Abstract][Full Text] [Related]
17. Preparation and in vivo evaluation of anti-plasmodial properties of artemisinin-loaded PCL-PEG-PCL nanoparticles.
Ramazani A; Keramati M; Malvandi H; Danafar H; Kheiri Manjili H
Pharm Dev Technol; 2018 Nov; 23(9):911-920. PubMed ID: 28851256
[TBL] [Abstract][Full Text] [Related]
18. Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject.
Joshi M; Pathak S; Sharma S; Patravale V
Int J Pharm; 2008 Nov; 364(1):119-26. PubMed ID: 18765274
[TBL] [Abstract][Full Text] [Related]
19. Curcumin-arteether combination therapy of Plasmodium berghei-infected mice prevents recrudescence through immunomodulation.
Vathsala PG; Dende C; Nagaraj VA; Bhattacharya D; Das G; Rangarajan PN; Padmanaban G
PLoS One; 2012; 7(1):e29442. PubMed ID: 22276114
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium chabaudi: efficacy of artemisinin + curcumin combination treatment on a clone selected for artemisinin resistance in mice.
Martinelli A; Rodrigues LA; Cravo P
Exp Parasitol; 2008 Jun; 119(2):304-7. PubMed ID: 18397786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]